{
    "organizations": [],
    "uuid": "c390392669217312695bd06b74e09d11c06c9d8f",
    "author": "",
    "url": "https://www.reuters.com/article/brief-celltrion-receives-eu-approval-for/brief-celltrion-receives-eu-approval-for-trastuzumab-biosimilar-idUSASM000J9E",
    "ord_in_thread": 0,
    "title": "BRIEF-Celltrion Receives EU Approval For Trastuzumab Biosimilar",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Celltrion Inc:\n* CELLTRION RECEIVES EU APPROVAL FOR TRASTUZUMAB BIOSIMILAR\n* CELLTRION-DECISION BY EU MEANS HERZUMA IS APPROVED FOR MARKETING IN 28 MEMBER STATES OF EU, IN ADDITION TO NORWAY, LIECHTENSTEIN AND ICELAND Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T03:34:00.000+02:00",
    "crawled": "2018-02-14T03:45:46.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "celltrion",
        "inc",
        "celltrion",
        "receives",
        "eu",
        "approval",
        "trastuzumab",
        "biosimilar",
        "eu",
        "mean",
        "herzuma",
        "approved",
        "marketing",
        "member",
        "state",
        "eu",
        "addition",
        "norway",
        "liechtenstein",
        "iceland",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}